DAX22.242 +0,8%ESt505.154 +0,8%Top 10 Crypto12,51 +5,1%Dow40.012 -0,2%Nas17.318 +0,9%Bitcoin83.301 +0,9%Euro1,1375 -0,1%Öl66,64 +0,2%Gold3.294 -1,6%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 Rheinmetall 703000 Tesla A1CX3T BYD A0M4W9 Alphabet A (ex Google) A14Y6F Deutsche Telekom 555750 RENK RENK73 Infineon 623100 Amazon 906866 Mercedes-Benz Group (ex Daimler) 710000 Siemens Energy ENER6Y Lufthansa 823212 Bayer BAY001 BASF BASF11 Volkswagen (VW) vz. 766403
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Wall Street uneins -- DAX geht höher ins Wochenende -- Alphabet meldet Gewinnsprung - Deal mit Palantir -- BYD mit mehr Umsatz und Gewinn -- Merck, Intel, BioNTech, Apple, Bayer im Fokus
Top News
Wall Street in Wartestellung: Dow leidet unter Gewinnmitnahmen - NASDAQ wankelmütig Wall Street in Wartestellung: Dow leidet unter Gewinnmitnahmen - NASDAQ wankelmütig
Delivery Hero-Aktie kräftig im Plus: Bernstein revidiert Kursziel - Einstufung bleibt aber Delivery Hero-Aktie kräftig im Plus: Bernstein revidiert Kursziel - Einstufung bleibt aber
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
Berliner Luft - Thomas Soltau und Feingold Research analysieren das Traderverhalten - heute im gettex-podcast mit Lars Reichel

10x Genomics A Aktie

NeuKaufenVerkaufen
Aktien-Sparplan anlegen
7,17 EUR +0,06 EUR +0,82 %
STU
8,18 USD -0,14 USD -1,62 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.900,35 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2PPQJ

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS88025U1097

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolTXG

10x Genomics A Aktien News

DatumMeistgelesen
PR Newswire10x Genomics to Report First Quarter 2025 Financial Results on May 8, 2025
PR Newswire10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products
PR Newswire10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis
Wer­bung10x Genomics A-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR Newswire10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference
PR Newswire10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025
PR NewswireChan Zuckerberg Initiative Launches Billion Cells Project with 10x Genomics and Ultima Genomics to Advance AI in Biology
PR Newswire10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025
PR Newswire10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
PR Newswire10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference
PR NewswireTechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative
PR Newswire10x Genomics Reports Third Quarter 2024 Financial Results
PR Newswire10x Genomics Delivers 'Single Cell for a Single Cent' with New Chromium Launches
PR Newswire10x Genomics Announces Preliminary Select Third Quarter 2024 Results
PR Newswire10x Genomics Announces Mega-Scale Single Cell Analysis for One Cent Per Cell at Human Cell Atlas General Meeting
PR NewswireLausanne Researchers Combine 10x Genomics' Chromium and Xenium for Novel Insights into Resistance and Potential Therapeutics for Brain Cancer
PR Newswire10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research
PR Newswire10x Genomics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
PR Newswire10x Genomics Announces Senior Leadership Changes
PR Newswire10x Genomics Reports Second Quarter 2024 Financial Results
PR Newswire10x Genomics Technology Supports TenK10K Project Led by Garvan Institute of Medical Research to Help Transform the Treatment of Complex Diseases
PR Newswire10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024
PR NewswireNew Insights Into Cleft Palate Unlocked With 10x Genomics' Single Cell and Spatial Technologies
PR Newswire10x Genomics Begins Commercial Shipments of Xenium Prime 5K Pan-Tissue and Pathways Panel
PR Newswire10x Genomics Launches 5,000-Plex Gene Panel for Xenium
PR Newswire10x Genomics to Present at the BofA Securities 2024 Healthcare Conference
PR Newswire10x Genomics Reports First Quarter 2024 Financial Results
PR Newswire10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024
PR Newswire10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay
PR Newswire10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel
PR Newswire10x Genomics Begins Commercial Shipments of Chromium GEM-X Products
PR Newswire10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference
PR Newswire10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024
PR Newswire10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X Technology
PR Newswire10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General Meeting
PR Newswire10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
PR Newswire10x Genomics Announces Preliminary Fourth Quarter and Full Year 2023 Results
PR Newswire10x Genomics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PR Newswire10x Genomics Launches Xenium Catalyst Network
PR NewswireIntegrative Study Conducted by 10x Genomics Combines Single Cell, Spatial and In Situ Analyses to Investigate Tumor Invasiveness
PR NewswireHigh Sensitivity and Specificity of the Xenium Platform from 10x Genomics Outperforms NanoString's CosMx and Vizgen's Merscope in Benchmarking Preprint
Wer­bung

10x Genomics A News

10x Genomics A News: auf dieser Seite finden Sie alle 10x Genomics A News und Nachrichten zur 10x Genomics A Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch 10x Genomics A News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um 10x Genomics A News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.